The Diabetic Footwear Revolution

糖尿病鞋革命

基本信息

  • 批准号:
    10077640
  • 负责人:
  • 金额:
    $ 89.09万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Diabetes is a growing healthcare problem in the UK - over 5 million people now have it. One of the problems with diabetes is that it can cause damage to the nerves and blood vessels in the feet, making them more vulnerable to injury and infection. A common foot problem in people with diabetes includes open sores (ulcers) on the foot that can be difficult to heal, this can have a large impact on patients, their families and wider society. Specifically designed shoes can be prescribed to people with diabetes which are made to help prevent foot problems like ulcers. However, these are expensive, take a long time to make and patients often don't like them. This patient dissatisfaction comes from a number of reasons, one being the lack of style options -- the shoes are designed only for function, not fashion. Some people also just find it difficult to adjust to prescribed footwear.This project will design and test a new and different way of making custom-made shoes for people with diabetes that may reduce the ulcer problem and provide patients with a better looking shoe which they feel more comfortable to wear. In the long term this can improve their diabetes management and so also cost the NHS less money. As part of this work, we want to talk to patients to find out what they think the problems with current footwear are and to the doctors to see how they think it should be improved. Fyous (the company doing the work) will then use its technology (called "polymorphic moulding") to make footwear that better suits the needs of people with diabetes.Fyous is working with another Company which already supplies the NHS and can help us access patients quickly. We are going to combine the Fyous "polymorphic moulding" technology with their shoes and then test the new product with patients and gather feedback on how they use them.Once the Fyous technology has been used to create the new shoes, we will explore how the benefits of the technology can be expanded to other medical products and other industries. We will research and develop demonstration products for other potential applications. Fyous' core "polymorphic moulding" technology allows custom-made products to be made to suit the different nature of people's body parts, and also to reduce the waste and environmental impact of other manufacturing techniques such as 3D printing. We then want to develop the technology so that it can be taken away from our factory floor and into a machine (similar to a 3D printer) which can be used by other companies. By making the polymorphic moulding machines themselves available to customers we will be able to get the technology used by more companies much more quickly and ultimately patients will benefit faster.
糖尿病是一个日益严重的医疗保健问题在英国-超过500万人现在有它.糖尿病的问题之一是,它会导致神经和血管在脚的损伤,使他们更容易受伤和感染.糖尿病患者常见的足部问题包括足部难以愈合的开放性溃疡(溃疡),这可能对患者,他们的家庭和更广泛的社会产生很大影响。专门设计的鞋子可以给糖尿病患者开处方,以帮助预防溃疡等足部问题。然而,这些都是昂贵的,需要很长时间,使病人往往不喜欢他们。这种病人的不满有很多原因,其中之一是缺乏款式选择--鞋子的设计只考虑功能,而不是时尚。有些人会觉得很难适应规定的鞋子。这个项目将设计和测试一种新的和不同的方式来为糖尿病患者定制鞋子,可以减少溃疡问题,并为患者提供一个更好看的鞋子,他们穿起来更舒服。从长远来看,这可以改善他们的糖尿病管理,因此也花费NHS更少的钱。作为这项工作的一部分,我们希望与患者交谈,了解他们认为目前鞋类的问题是什么,并与医生交谈,了解他们认为应该如何改进。Fyous(从事这项工作的公司)将利用其技术(称为“多形态成型”)制造更适合糖尿病患者需求的鞋类。Fyous正在与另一家公司合作,该公司已经为NHS提供产品,可以帮助我们快速接触患者。我们将联合收割机的“多形态成型”技术与他们的鞋子结合起来,然后在患者身上测试新产品,并收集他们如何使用它们的反馈。一旦Fyous技术被用于制造新鞋子,我们将探索如何将该技术的好处扩展到其他医疗产品和其他行业。我们将研究和开发其他潜在应用的示范产品。Fyous的核心“多形态成型”技术允许定制产品,以适应人们身体部位的不同性质,并减少其他制造技术(如3D打印)的浪费和环境影响。然后,我们希望开发这项技术,以便它可以从我们的工厂车间转移到其他公司可以使用的机器(类似于3D打印机)中。通过向客户提供多形态成型机,我们将能够更快地让更多公司使用该技术,最终患者将更快受益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship

相似海外基金

Footwear Innovation to Improve Safety for Female Turf Sport Players (“FemFITS”)
鞋类创新可提高女性草地运动运动员的安全性 (“FemFITS”)
  • 批准号:
    10098494
  • 财政年份:
    2024
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Collaborative R&D
Impact of Improving Footwear Options for Women Veterans with Amputations
改善截肢女退伍军人鞋类选择的影响
  • 批准号:
    10641398
  • 财政年份:
    2023
  • 资助金额:
    $ 89.09万
  • 项目类别:
In vivo thickness and dynamic behaviour of the heel fat pad during ageing: biomechanical and anthropological impact of footwear.
老化过程中脚跟脂肪垫的体内厚度和动态行为:鞋类的生物力学和人类学影响。
  • 批准号:
    MR/Y010140/1
  • 财政年份:
    2023
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Research Grant
Customisable 3D printed and recyclable footwear
可定制的 3D 打印和可回收鞋类
  • 批准号:
    10076515
  • 财政年份:
    2023
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Grant for R&D
Assessment and gap analysis of current poor medical footwear provisions.
当前不良医用鞋供应的评估和差距分析。
  • 批准号:
    10044039
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Grant for R&D
Treekind(R), a unique PU-free leather alternative: Material analysis to produce consistent flex performance for the footwear industry
Treekind(R),一种独特的不含 PU 的皮革替代品:材料分析可为制鞋行业提供一致的弯曲性能
  • 批准号:
    10022668
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Collaborative R&D
Developing a low-cost, scalable, automated design-through-manufacture pipeline for patient specific footwear as an early treatment of diabetic foot u
开发一种低成本、可扩展、自动化的从设计到制造的流程,用于患者专用鞋类,作为糖尿病足的早期治疗
  • 批准号:
    2751144
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Studentship
Biomechanics and performance of slip resistant soles for personal and work footwear
个人鞋和工作鞋防滑鞋底的生物力学和性能
  • 批准号:
    570347-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Alliance Grants
Design and Evaluation of Slip Resistant Winter Footwear
冬季防滑鞋的设计与评价
  • 批准号:
    RGPIN-2017-06655
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
    Discovery Grants Program - Individual
Portable, robotic footwear for real-time control of foot-ground stiffness
用于实时控制足部地面刚度的便携式机器人鞋
  • 批准号:
    10678900
  • 财政年份:
    2022
  • 资助金额:
    $ 89.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了